TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Roche Diagnostics Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
50,208
|
51,853
|
62,411 |
| Financial expenses |
6
|
1
|
2 |
| Earnings before taxes |
1,512
|
1,719
|
2,217 |
| EBITDA |
3,716
|
3,551
|
4,577 |
| Total assets |
22,778
|
22,804
|
25,186 |
| Current assets |
16,552
|
18,518
|
20,354 |
| Current liabilities |
10,646
|
11,596
|
14,581 |
| Equity capital |
11,747
|
11,001
|
10,559 |
| - share capital |
811
|
809
|
880 |
| Employees (average) |
97
|
97
|
105 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.6%
|
48.2%
|
41.9% |
| Turnover per employee |
518
|
535
|
594 |
| Profit as a percentage of turnover |
3.0%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
6.7%
|
7.5%
|
8.8% |
| Current ratio |
155.5%
|
159.7%
|
139.6% |
| Return on equity (ROE) |
12.9%
|
15.6%
|
21.0% |
| Change turnover |
-1,796
|
-5,503
|
2,971 |
| Change turnover % |
-3%
|
-10%
|
5% |
| Chg. No. of employees |
0
|
-8
|
4 |
| Chg. No. of employees % |
0%
|
-8%
|
4% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.